Wireless phone may increase risk of gliomas
the ONA take:
The continual use of a mobile phone increases the odds of developing glioma, an often-fatal brain cancer, according to Swedish researchers. Lead researcher Dr. Lennart Hardell stated that the risk of brain cancer is three times higher after 25 years or more of mobile phone use.
According to the study data, those using a mobile device for less than a year are half as likely to develop glioma when compared to those who reported using a wireless phone for 20 years or more. The effect of mobile use on the likelihood of developing other brain cancers was not examined.
These results contrasted with an earlier study released in 2010, that found no strong evidence of a link between continual mobile device use and increased changes of brain cancer development. The earlier study, financially supported in part by phone companies, is the largest study done on the topic.
The recent study suffers from similar limitations to other case control studies, in that the participants may not always remember their behaviors over a long span of time, which could impact the data. A study conducted in U.S. that examined cell phase use in Californians did however find that the rate of malignant tumors in the area of the brain nearest to where most people hold their phone increased considerably, even as incidence of brain gliomas lowered.
Additional study is warranted.
Risk of brain cancer is three times higher after 25 years or more of mobile phone use.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|